Usafsam/PH - roche immuno and ctng BPA reagents, kits and consumables - call 0006 - may 2025

Ended Awarded Last action

Contract number
FA239625FB198
Awardee
Awarding agency
Obligated
$332,472

Award facts

Contract value 100% obligated
$332,471.70 Current and potential, with all options
Completion date
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a BPA call valued at $332,471.70 to Roche Diagnostics Corporation for immunology and coagulation reagents, kits, and consumables. This contract was executed under an existing Blanket Purchase Agreement and represents a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. The award carries no set-aside designation, indicating open competition for the procurement. Roche Diagnostics Corporation, headquartered in Indianapolis, Indiana, is a global leader in in vitro diagnostics and laboratory solutions, supplying comprehensive diagnostic capabilities to military and federal healthcare systems.

Roche Diagnostics maintains an extensive federal contracting presence with the Defense Health Agency through multiple indefinite delivery contracts and blanket purchase agreements valued in the millions of dollars. The company's product portfolio for federal customers includes advanced laboratory analyzers, reagents, testing systems, and associated consumables across molecular diagnostics, immunochemistry, histology, and point-of-care testing platforms. This specific call order for immunology and coagulation reagents and kits aligns with Roche's established role as a primary supplier of diagnostic testing materials to military medical facilities and the broader Defense Health Agency network, supporting laboratory testing operations across the military healthcare enterprise.

Quick answers

Who was awarded contract FA239625FB198?

FA239625FB198 was awarded to Roche Diagnostics Corporation by Air Force (Department of Defense) on August 5, 2025.

How much is contract FA239625FB198 worth?

The government has obligated $332,472 on FA239625FB198.

Which agency awarded contract FA239625FB198?

Air Force (Department of Defense) awarded FA239625FB198, with funding from Defense Health Agency (Department of Defense).

Is contract FA239625FB198 an order under another contract?

Yes. FA239625FB198 is a BPA call under FA239625AB002, a blanket purchase agreement.

Was contract FA239625FB198 competed?

The extent of competition for FA239625FB198 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award